Related Experiment Video

Updated: Apr 18, 2026

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

7.5K

[When defense becomes dangerous--transcription factor Nrf2 and cancer]

Adam Krysztofiak1, Violetta Krajka-Kuźniak1

  • 1Katedra Biochemii Farmaceutycznej Uniwersytetu Medycznego im. Karola Marcinkowskiego w Poznaniu.

Postepy Higieny I Medycyny Doswiadczalnej (Online)
|January 24, 2015
PubMed

Insights

The transcription factor Nrf2 regulates protective genes, impacting cancer prevention and drug resistance. Understanding Nrf2

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Cancer Research

Background:

  • Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor controlling cytoprotective genes.
  • Nrf2 activation involves modifications to its inhibitor, Keap1, and phosphorylation by kinases.
  • Nrf2 influences the expression of phase II enzymes crucial for detoxifying carcinogens.

Purpose of the Study:

  • To summarize current knowledge on the role of Nrf2 in tumorigenesis.
  • To assess the dual role of Nrf2 in cancer chemoprevention and drug resistance.
  • To highlight the importance of understanding Nrf2 for cancer treatment strategies.

Main Methods:

  • Literature review of Nrf2 pathway.
  • Analysis of Nrf2's role in carcinogen inactivation.
  • Examination of Nrf2's impact on drug metabolism and resistance.

Main Results:

  • Nrf2 activation induces enzymes that inactivate potential carcinogens, suggesting chemopreventive potential.
  • Nrf2-regulated enzymes can reduce drug efficacy and contribute to drug resistance.
  • The precise role of Nrf2 in cancer is complex, with both beneficial and detrimental effects.

Conclusions:

  • A comprehensive understanding of Nrf2 is essential for evaluating its up-regulation in cancer prevention and therapy.
  • Nrf2 modulation presents a potential strategy for cancer chemoprevention.
  • Further research is needed to fully elucidate Nrf2's complex involvement in tumorigenesis and drug resistance.

More Related Videos

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia09:52

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

Published on: December 4, 2018

8.2K

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
8.1K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.9K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
6.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.8K
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
84.5K